Expression and significant roles of the long non-coding RNA CASC19/miR-491-5p/HMGA2 axis in the development of gastric cancer

Table 1 Relationship between CASC19 and clinicopathologic characteristics

Patient-related factors	CASC19		χ2	P value
	Low (n = 36)	High (n = 36)
Gender			0.250	0.617
Male	25	23
Female	11	13
Age (years)			2.724	0.099
< 60	15	22
≥ 60	21	14
Tumor sizes			14.629	< 0.001
< 5 cm	29	13
≥ 5 cm	7	23
Differentiation grade			1.787	0.181
Poor	24	29
Well	12	7
Tumor location			5.077	0.079
Upper	3	3
Middle	9	18
Lower	24	15
N stage			19.505	< 0.001
N0	22	4
N1-N3	14	32
T stage			9.000	0.003
T1-T2	18	6
T3-T4	18	30